CONFERENCE COVERAGE
American Headache Society
Annual Meeting
- Eptinezumab Robustly Prevents Migraine in Patients With Prior Treatment Failures
- Rates of Response to Atogepant for Episodic Migraine in 1 Year
- Noninvasive Vagal Nerve Stimulation: A Potential Treatment for Visual Snow?
- Celecoxib Effective for Migraine Pain Relief, Symptoms Regardless of Aura Status
- B Vitamins Supplementation as Treatment for Episodic Migraine in Women
- Ubrogepant Most Effective in Mild vs Moderate or Severe Headache Pain Intensity
- Galcanezumab Reduces Episodic Migraine Days, Improves Patient Quality of Life
- Ubrogepant Combined with OnabotA Effective for Breakthrough Migraine
- Pediatric Anxiety and BoNT-A Therapy Responsiveness in Chronic Migraine
- Preventive Treatment Failure in Episodic Migraine Tied to Worse Outcomes
- Comorbid Sleep Disorders More Common in Patients With Chronic Migraine
- Impact of High-Fat Meals on the Pharmacokinetics of Atogepant for Migraine
Latest Tweets
Follow
@NeuroAdvisor
Conference Coverage from
